5tgk
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 5tgk is ON HOLD until | + | The entry 5tgk is ON HOLD until Apr 30 2019 |
Authors: Wang, C., Aleksandrov, A.A., Yang, Z., Forouhar, F., Proctor, E., Kota, P., An, J., Kaplan, A., Khazanov, N., Boel, G., Stockwell, B.R., Senderowitz, H., Dokholyan, N.V., Riordan, J.R., Brouillette, C.G., Hunt, J.F. | Authors: Wang, C., Aleksandrov, A.A., Yang, Z., Forouhar, F., Proctor, E., Kota, P., An, J., Kaplan, A., Khazanov, N., Boel, G., Stockwell, B.R., Senderowitz, H., Dokholyan, N.V., Riordan, J.R., Brouillette, C.G., Hunt, J.F. | ||
Revision as of 05:06, 28 March 2018
Unreleased structure
The entry 5tgk is ON HOLD until Apr 30 2019
Authors: Wang, C., Aleksandrov, A.A., Yang, Z., Forouhar, F., Proctor, E., Kota, P., An, J., Kaplan, A., Khazanov, N., Boel, G., Stockwell, B.R., Senderowitz, H., Dokholyan, N.V., Riordan, J.R., Brouillette, C.G., Hunt, J.F.
Description: Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with dATP
Categories: Unreleased Structures | Senderowitz, H | Kaplan, A | Forouhar, F | Boel, G | Wang, C | Brouillette, C.G | Yang, Z | Khazanov, N | Aleksandrov, A.A | Stockwell, B.R | Kota, P | Riordan, J.R | An, J | Dokholyan, N.V | Hunt, J.F | Proctor, E
